SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in EuropeSteven H J Hageman, Gunnar Engström, Adam S. Butterworth et al.|European Heart Journal|2021Cited by 1.7k
Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk ConsortiumFabian J. Brunner, Stefano Signorini, Christoph Waldeyer et al.|The Lancet|2019Cited by 304
Lipoprotein(a) and the risk of cardiovascular disease in the European population: results from the BiomarCaRE consortiumChristoph Waldeyer, Stefan Blankenberg, Nataliya Makarova et al.|European Heart Journal|2017Cited by 268
High-sensitivity cardiac troponin I in the general population – defining reference populations for the determination of the 99th percentile in the Gutenberg Health StudyTanja Zeller, Karl J. Lackner, Francisco Ojeda et al.|Clinical Chemistry and Laboratory Medicine (CCLM)|2014Cited by 80
Modifiable lifestyle risk factors and C-reactive protein in patients with coronary artery disease: Implications for an anti-inflammatory treatment target populationChristopher Blaum, Christoph Waldeyer, Fabian J. Brunner et al.|European Journal of Preventive Cardiology|2019Cited by 57